Vincerx Pharma Inc expected to post a loss of 37 cents a share - Earnings Preview

Vincerx Pharma

22/03/2024 11:03

* Vincerx Pharma Inc  VINC.OQ   VINC.O  is expected to show
no
change in quarterly revenue when it reports  results on March 26
(estimated) for the period ending December 31 2023
    * 
    * ​LSEG's mean analyst estimate for Vincerx Pharma Inc is
for a
loss of 37 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Vincerx
Pharma
Inc is $9.00​, above​ its last closing price of $5.45. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Sep. 30 2023  -0.46       -0.46      -0.46     Met     -0.7
 Jun. 30 2023  -0.61       -0.60      -0.52     Beat    12.9
 Mar. 31 2023  -0.52       -0.52      -0.68     Missed  -30.8​
 Dec. 31 2022              -0.61      -0.65     Missed  -5.7
 ​​Sep.        -0.64       -0.55      -0.80     Missed  -44.8
 30 2022                                                
 Jun. 30 2022  -0.82       -0.79      -0.88     Missed  -10.7​
 Mar. 31 2022  -0.72       -0.76      -0.79     Missed  -4.5
 Dec. 31 2021  -0.87       -0.93      -0.31     Beat    66.7
 This summary was machine generated March 22 at 11:03 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)